ADC Therapeutics SA (ADCT)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Ameet Mallik
Employees:
310
BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, V8, 1066
41 21 653 02 00
Are you looking for this stock instead?
ADC Therapeutics SA develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. The company is also developing camidanlumab tesirine, an ADC that has completed Phase I clinical trial.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|